Sarepta therapeutics set to join s&p midcap 400

New york , may 29, 2024 /prnewswire/ -- sarepta therapeutics inc. (nasd: srpt) will replace shockwave medical inc. (nasd: swav) in the s&p midcap 400 effective prior to the opening of trading on monday, june 3. s&p 500 constituent johnson & johnson (nyse: jnj) is acquiring shockwave medical in a deal expected to be completed soon pending final closing conditions.
SPGI Ratings Summary
SPGI Quant Ranking